A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT06839872 · WITHDRAWN
Trial details
- NCT number
- NCT06839872
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2028-07-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.